Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3320 participants.
Also called NCT04416581
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 3,320 participants
- Sponsor
- Registry
-
NCT04416581
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT04416581. Randomized; quadruple masking; primary purpose prevention. Start 2021-05-12 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
- Acronym
- PROTECT-HBR
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Condition
- Acute Coronary Syndrome
- Condition
- Myocardial Infarction
- Intervention (Drug)
- PPI
- Intervention (Drug)
- P-CAB 50
- Lead sponsor
- Duk-Woo Park, MD
Record details
- Record id
cardio:ct-nct04416581- Content hash
87e2d0f0e9757265289c92a2b1041277a96bd3eeff63792c054b0530dc020fe9